Carmiel, Israel

Uri Hanania

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Path of Uri Hanania

Introduction

Uri Hanania, an accomplished inventor based in Carmiel, Israel, has made significant strides in the field of biotechnology. With a remarkable portfolio of six patents, Hanania focuses on developing chimeric polypeptides and therapeutic methods utilizing plant cells. His contributions are particularly valuable in addressing various medical conditions associated with TNF Alpha.

Latest Patents

Uri Hanania's most recent patents showcase his innovative work in biotechnology. His first patent involves the creation of chimeric polypeptides and polynucleotides encoding the same. This invention enables the production of plant-derived chimeric polypeptides, which have promising applications in medicine. Another notable patent involves a method for treating TNF Alpha-associated medical conditions, such as obesity, metabolic syndrome, diabetes, and liver diseases. This method entails enterally administering a therapeutically effective amount of plant cells that express TNF Alpha polypeptide inhibitors, offering a novel therapeutic approach.

Career Highlights

Throughout his career, Hanania has worked with prominent organizations in the biotechnology sector. Notably, he has contributed his expertise at Protalix Ltd., a leading biotechnology company known for its focus on plant-made pharmaceuticals. Additionally, Hanania has been involved with Hadasit Medical Research Services and Development Ltd., further solidifying his reputation in the industry.

Collaborations

In his professional journey, Uri Hanania has collaborated with talented coworkers, including Yoseph Shaaltiel and Tali Kizhner. These collaborations have enhanced the innovative potential of his research and enabled the development of cutting-edge solutions in biotechnology.

Conclusion

Uri Hanania's dedication to innovation and his impressive portfolio of patents position him as a noteworthy inventor in the biotechnology field. His work with chimeric polypeptides and plant-based therapies paves the way for significant advancements in medical treatment, benefiting countless individuals facing TNF Alpha-associated health challenges. As we continue to explore the contributions of inventors like Hanania, it becomes increasingly clear that their innovations can lead to transformative changes in health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…